186 related articles for article (PubMed ID: 35857204)
1. Lung cancer survival prediction and biomarker identification with an ensemble machine learning analysis of tumor core biopsy metabolomic data.
Miller HA; van Berkel VH; Frieboes HB
Metabolomics; 2022 Jul; 18(8):57. PubMed ID: 35857204
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival.
Miller HA; Rai SN; Yin X; Zhang X; Chesney JA; van Berkel VH; Frieboes HB
Metabolomics; 2022 May; 18(5):31. PubMed ID: 35567637
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data.
Miller HA; Yin X; Smith SA; Hu X; Zhang X; Yan J; Miller DM; van Berkel VH; Frieboes HB
Lung Cancer; 2021 Jun; 156():20-30. PubMed ID: 33882406
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic differentiation of tumor core versus edge in glioma.
Baxter ME; Miller HA; Chen J; Williams BJ; Frieboes HB
Neurosurg Focus; 2023 Jun; 54(6):E4. PubMed ID: 37283447
[TBL] [Abstract][Full Text] [Related]
5. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
6. Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.
Siah KW; Khozin S; Wong CH; Lo AW
JCO Clin Cancer Inform; 2019 Sep; 3():1-11. PubMed ID: 31539267
[TBL] [Abstract][Full Text] [Related]
7. A screening test proposal for congenital defects based on maternal serum metabolomics profile.
Troisi J; Lombardi M; Scala G; Cavallo P; Tayler RS; Symes SJK; Richards SM; Adair DC; Fasano A; McCowan LM; Guida M
Am J Obstet Gynecol; 2023 Mar; 228(3):342.e1-342.e12. PubMed ID: 36075482
[TBL] [Abstract][Full Text] [Related]
8. A new hybrid ensemble machine-learning model for severity risk assessment and post-COVID prediction system.
Shakhovska N; Yakovyna V; Chopyak V
Math Biosci Eng; 2022 Apr; 19(6):6102-6123. PubMed ID: 35603393
[TBL] [Abstract][Full Text] [Related]
9. Comparison of nomogram with machine learning techniques for prediction of overall survival in patients with tongue cancer.
Alabi RO; Mäkitie AA; Pirinen M; Elmusrati M; Leivo I; Almangush A
Int J Med Inform; 2021 Jan; 145():104313. PubMed ID: 33142259
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an ensemble machine-learning model for predicting early mortality among patients with bone metastases of hepatocellular carcinoma.
Long Z; Yi M; Qin Y; Ye Q; Che X; Wang S; Lei M
Front Oncol; 2023; 13():1144039. PubMed ID: 36890826
[TBL] [Abstract][Full Text] [Related]
11. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers for risk assessment of arsenicosis based on untargeted metabolomics and machine learning algorithms.
Zhang J; Ma L; Li B; Chen X; Wang D; Zhang A
Sci Total Environ; 2023 Apr; 870():161861. PubMed ID: 36716877
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of stacked ensemble model performance to predict clinical outcomes: A COVID-19 study.
Kablan R; Miller HA; Suliman S; Frieboes HB
Int J Med Inform; 2023 Jul; 175():105090. PubMed ID: 37172507
[TBL] [Abstract][Full Text] [Related]
14. A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinoma.
Lu L; Wang D; Wang L; E L; Guo P; Li Z; Xiang J; Yang H; Li H; Yin S; Schwartz LH; Xie C; Zhao B
Eur Radiol; 2020 Jul; 30(7):3614-3623. PubMed ID: 32086583
[TBL] [Abstract][Full Text] [Related]
15. A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Robinson EJ; Orton M; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
EBioMedicine; 2022 Mar; 77():103911. PubMed ID: 35248997
[TBL] [Abstract][Full Text] [Related]
16. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J
J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630
[TBL] [Abstract][Full Text] [Related]
17. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
[TBL] [Abstract][Full Text] [Related]
18. Discrepancies in metabolomic biomarker identification from patient-derived lung cancer revealed by combined variation in data pre-treatment and imputation methods.
Miller HA; Emam R; Lynch CM; Bockhorst S; Frieboes HB
Metabolomics; 2021 Mar; 17(4):37. PubMed ID: 33772663
[TBL] [Abstract][Full Text] [Related]
19. Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage II-III Non-Small Cell Lung Cancer.
Sepehri S; Tankyevych O; Upadhaya T; Visvikis D; Hatt M; Cheze Le Rest C
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33918681
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
